A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease


Total Award Amount

  • 101420.00
  • Direct Costs

  • 78015.00
  • Sponsor Award Id

  • Contributor

  • Maria Acosta Lara   Investigator  
  • Maria I. Danila MD, MSc, MSPH   Investigator  
  • Steven Duncan   Principal Investigator  
  • Tejaswini Kulkarni   Investigator  
  • Tracy Luckhardt   Investigator